Yahoo
NYSE - Delayed Quote USD

Colgate-Palmolive Company (CL)

88.77 -1.32 (-1.47%)
At close: September 4 at 4:00:02 PM EDT
88.85 +0.08 (+0.09%)
After hours: September 4 at 7:53:24 PM EDT
Trade CL on Coinbase
Chart Range Bar
Loading chart for CL

What's happening with CL?

9m ago
Powered by Yahoo Scout

Colgate-Palmolive (CL) shows strong year-to-date performance, with 14% growthand solid Q2 results, but faces valuation scrutiny and regional sales challenges. Analysts maintain a Moderate Buyrating with a price target of $98.09, indicating potential upside.

Powered by Yahoo Scout
  • Previous Close 90.09
  • Open 89.53
  • Bid 88.31 x 30000
  • Ask 88.82 x 150000
  • Day's Range 88.68 - 90.50
  • 52 Week Range 74.55 - 99.33
  • Volume 3,977,477
  • Avg. Volume 4,715,144
  • Market Cap (intraday) 70.765B
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) 34.95
  • EPS (TTM) 2.54
  • Earnings Date Oct 30, 2026
  • Forward Dividend & Yield 2.12 (2.39%)
  • Ex-Dividend Date Jul 20, 2026
  • 1y Target Est 98.95

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

www.colgatepalmolive.com

33,600

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CL
14.38%
S&P 500 (^GSPC)
12.75%

1-Year Return

CL
8.75%
S&P 500 (^GSPC)
18.71%

3-Year Return

CL
29.98%
S&P 500 (^GSPC)
70.93%

5-Year Return

CL
28.36%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 5.36B
Earnings 693M
Profit Margin 12.93%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
4B
5B
0.0%
5.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

87.00
98.95 Average
88.77 Current
110.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/3/2026
Analyst UBS
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 106 -> 109

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.68%

  • Return on Assets (ttm)

    15.84%

  • Return on Equity (ttm)

    267.37%

  • Revenue (ttm)

    21.05B

  • Net Income Avi to Common (ttm)

    2.04B

  • Diluted EPS (ttm)

    2.54

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.45B

  • Total Debt/Equity (mrq)

    1,388.16%

  • Levered Free Cash Flow (ttm)

    3.46B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: